245 related articles for article (PubMed ID: 12519632)
1. Paraoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
Costa LG; Richter RJ; Li WF; Cole T; Guizzetti M; Furlong CE
Biomarkers; 2003; 8(1):1-12. PubMed ID: 12519632
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity.
Costa LG; Giordano G; Cole TB; Marsillach J; Furlong CE
Toxicology; 2013 May; 307():115-22. PubMed ID: 22884923
[TBL] [Abstract][Full Text] [Related]
3. Catalytic efficiency determines the in-vivo efficacy of PON1 for detoxifying organophosphorus compounds.
Li WF; Costa LG; Richter RJ; Hagen T; Shih DM; Tward A; Lusis AJ; Furlong CE
Pharmacogenetics; 2000 Dec; 10(9):767-79. PubMed ID: 11191881
[TBL] [Abstract][Full Text] [Related]
4. The PON1 gene and detoxication.
Furlong CE; Li WF; Brophy VH; Jarvik GP; Richter RJ; Shih DM; Lusis AJ; Costa LG
Neurotoxicology; 2000 Aug; 21(4):581-7. PubMed ID: 11022865
[TBL] [Abstract][Full Text] [Related]
5. Gene-environmental interactions and organophosphate toxicity.
Povey AC
Toxicology; 2010 Dec; 278(3):294-304. PubMed ID: 20156521
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase and susceptibility to organophosphorus poisoning in farmers dipping sheep.
Mackness B; Durrington P; Povey A; Thomson S; Dippnall M; Mackness M; Smith T; Cherry N
Pharmacogenetics; 2003 Feb; 13(2):81-8. PubMed ID: 12563177
[TBL] [Abstract][Full Text] [Related]
7. Genetically determined susceptibility to organophosphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism.
Furlong CE; Li WF; Costa LG; Richter RJ; Shih DM; Lusis AJ
Neurotoxicology; 1998; 19(4-5):645-50. PubMed ID: 9745924
[TBL] [Abstract][Full Text] [Related]
8. Genetic and temporal determinants of pesticide sensitivity: role of paraoxonase (PON1).
Furlong CE; Li WF; Richter RJ; Shih DM; Lusis AJ; Alleva E; Costa LG
Neurotoxicology; 2000; 21(1-2):91-100. PubMed ID: 10794389
[TBL] [Abstract][Full Text] [Related]
9. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
10. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.
Costa LG; Li WF; Richter RJ; Shih DM; Lusis A; Furlong CE
Chem Biol Interact; 1999 May; 119-120():429-38. PubMed ID: 10421480
[TBL] [Abstract][Full Text] [Related]
11. The toxicity of mixtures of specific organophosphate compounds is modulated by paraoxonase 1 status.
Cole TB; Jansen K; Park S; Li WF; Furlong CE; Costa LG
Adv Exp Med Biol; 2010; 660():47-60. PubMed ID: 20221870
[TBL] [Abstract][Full Text] [Related]
12. Genetic variability in the cytochrome P450-paraoxonase 1 (PON1) pathway for detoxication of organophosphorus compounds.
Furlong CE
J Biochem Mol Toxicol; 2007; 21(4):197-205. PubMed ID: 17936934
[TBL] [Abstract][Full Text] [Related]
13. The Relationship between PON1 phenotype and PON1-192 genotype in detoxification of three oxons by human liver.
Mutch E; Daly AK; Williams FM
Drug Metab Dispos; 2007 Feb; 35(2):315-20. PubMed ID: 17132760
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of paraoxonase (PON1) and their significance in clinical toxicology of organophosphates.
Costa LG; Cole TB; Furlong CE
J Toxicol Clin Toxicol; 2003; 41(1):37-45. PubMed ID: 12645966
[TBL] [Abstract][Full Text] [Related]
15. Paraoxonase 1 (PON1) status and substrate hydrolysis.
Richter RJ; Jarvik GP; Furlong CE
Toxicol Appl Pharmacol; 2009 Feb; 235(1):1-9. PubMed ID: 19071155
[TBL] [Abstract][Full Text] [Related]
16. Effect of organophosphate intoxication on human serum paraoxonase.
Sözmen EY; Mackness B; Sözmen B; Durrington P; Girgin FK; Aslan L; Mackness M
Hum Exp Toxicol; 2002 May; 21(5):247-52. PubMed ID: 12141395
[TBL] [Abstract][Full Text] [Related]
17. Paraoxonase 1 (PON1) modulates the toxicity of mixed organophosphorus compounds.
Jansen KL; Cole TB; Park SS; Furlong CE; Costa LG
Toxicol Appl Pharmacol; 2009 Apr; 236(2):142-53. PubMed ID: 19371602
[TBL] [Abstract][Full Text] [Related]
18. Paraoxonase 1 status as a risk factor for disease or exposure.
Richter RJ; Jarvik GP; Furlong CE
Adv Exp Med Biol; 2010; 660():29-35. PubMed ID: 20221868
[TBL] [Abstract][Full Text] [Related]
19. Analysis of paraoxonase (PON1) L55M status requires both genotype and phenotype.
Brophy VH; Jarvik GP; Richter RJ; Rozek LS; Schellenberg GD; Furlong CE
Pharmacogenetics; 2000 Jul; 10(5):453-60. PubMed ID: 10898114
[TBL] [Abstract][Full Text] [Related]
20. Human serum paraoxonase.
Mackness B; Durrington PN; Mackness MI
Gen Pharmacol; 1998 Sep; 31(3):329-36. PubMed ID: 9703197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
